ArticleScience advances2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Daniel Rosenblum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
304 papers cite itlatest 60 shown
this paperpooled itcites it